
American Medical Technologists (AMT) Home
American Medical Technologists (AMT) is a not-for-profit association of allied health professionals. In addition to certification, AMT provides members ongoing support to maintain …
American Medical Technologists Login
Access the American Medical Technologists member login page for exclusive resources, updates, and professional support tailored for medical technologists.
Alternative Minimum Tax (AMT): What It Is and How It Works
Feb 26, 2025 · The alternative minimum tax (AMT) is a tax levied by the U.S. government on entities with significantly high incomes. It ensures they pay a minimum amount of tax.
Get Certified with AMT - americanmedtech.org
If you are late, turned away, or do not appear for your examination, you must pay a retesting fee to reschedule your examination. Want to find a location before you schedule? Click Schedule …
My AMT Portal - americanmedtech.org
Manage your certifications, update your profile, and explore exclusive resources to support your healthcare career. Log in now to stay connected with AMT.
Verify AMT Certification - americanmedtech.org
Verify your AMT certification status easily. Check if an individual holds a current certification with our straightforward online tool. Ensure compliance today.
About American Medical Technologists
AMT exams are created, administered, and analyzed with industry standards and advanced methods by expert committees. All competency-based exams are accredited by the National …
American Medical Technologists CE & Meetings
AMT provides diverse continuing education (CE) options to support allied health professionals in maintaining and enhancing their skills. Earn CE points through STEP online, On-Demand …
Home - American Medical Technologists
To encourage healthcare professionals to verify their skills and competence, learn and grow in their chosen profession, and maintain quality in the workplace. Copyright 2024. All rights …
uniQure's gene therapy for Huntington's hits FDA roadblock
Nov 3, 2025 · The FDA no longer agrees that data from a phase 1/2 study of the gene therapy, coded AMT-130, are enough to support a regulatory application for approval, uniQure said …